Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-15

Clinical Trial Update: Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating seroprevalence of neutralizing antibodies against Japanese Encephalitis virus in 6-year-old children across five immunization st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhejiang Provincial Center for Disease Control and Prevention | Conditions: Japanese Encephalitis, Vaccine Preventable Disease | Phase 4 | Status: UNKNOWN